Addison Advisors LLC Purchases 1,106 Shares of Haleon plc (NYSE:HLN)

Addison Advisors LLC grew its position in Haleon plc (NYSE:HLN) by 28.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,954 shares of the company’s stock after acquiring an additional 1,106 shares during the period. Addison Advisors LLC’s holdings in Haleon were worth $47,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of HLN. Allspring Global Investments Holdings LLC lifted its stake in shares of Haleon by 44.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 25,560 shares of the company’s stock valued at $270,000 after acquiring an additional 7,856 shares during the last quarter. International Assets Investment Management LLC acquired a new stake in Haleon during the 3rd quarter worth about $3,700,000. Ballentine Partners LLC grew its holdings in Haleon by 53.1% during the 3rd quarter. Ballentine Partners LLC now owns 22,831 shares of the company’s stock worth $242,000 after acquiring an additional 7,918 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in Haleon by 3.0% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 61,016 shares of the company’s stock worth $646,000 after acquiring an additional 1,766 shares during the period. Finally, Fortitude Family Office LLC acquired a new stake in shares of Haleon in the 3rd quarter valued at about $28,000. 6.67% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Price Performance

Shares of NYSE HLN opened at $10.16 on Wednesday. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The stock has a market cap of $45.97 billion, a price-to-earnings ratio of 29.87, a PEG ratio of 2.82 and a beta of 0.28. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The firm’s 50-day simple moving average is $9.57 and its 200 day simple moving average is $9.83.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.